Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
The coronavirus disease of 2019 (COVID-19) has caused significant morbidity and mortality among infected individuals across the world. High transmissibility rate of the causative virus – Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – has led to immense strain and bottlenecking of the...
Guardado en:
Autores principales: | Kritika Srinivasan, Mana Rao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85abae68d6764e3ea80fae177c22c749 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical characteristics of family-clustered onset of coronavirus disease 2019 in Jilin Province, China
por: Na Du, et al.
Publicado: (2020) -
Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing
por: Gregory Mathez, et al.
Publicado: (2021) -
Coronavirus disease 2019 and the gut–lung axis
por: Dan Zhou, et al.
Publicado: (2021) -
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
por: Yinjie Gao, et al.
Publicado: (2020) -
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview
por: Matheus Negri Boschiero, et al.
Publicado: (2021)